NCT00206258View on ClinicalTrials.gov

The Role of Amylin and Glucagon in T1DM

PHASE3CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

August 31, 2005

Conditions

Type 1 Diabetes

Interventions

DRUG

Pramlintide and glucagon

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors

lead

Baylor College of Medicine

OTHER

NCT00206258 - The Role of Amylin and Glucagon in T1DM | Biotech Hunter | Biotech Hunter